The current analyst and expert consensus on Natus Medical is Buy with 0 strong sell and 3 strong buy opinions. The current projected target price consensus is 51.0 with 2 analysts opinions. The most common way Natus Medical Incorp analysists use to provide recommendation to public is financial statements analysis. Many experts also interview Natus Medical executives and customers to further validate their buy or sell advice. Please note, the number of analysists providing the opinion is not sufficient to provide adequate consensus on Natus Medical. We encourage you to use your own analysis of Natus Medical Incorp to validate this buy or sell advice. Natus Medical buy or sell recommendation module provides average expert sentiment on the projected Natus Medical Incorp target price to derive its highest and lowest estimates based on projected price volatility of 5.656. Check also Macroaxis Advice on Natus Medical to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.